Gene Silencing Porphyria Treatment, Givlaari, Finally Wins Over England’s NICE Amid Stellar Long-Term Data
XTalks
OCTOBER 26, 2021
AIP is a type of acute hepatic porphyria (AHP) that can cause severe pain and neurological symptoms, including seizures, due to a buildup of toxic neuroproteins. The treatment came with an initial price tag of $39,000 per vial, which amounts to a total of $575,00 each year. This leads to lowering of ALA and PBG levels.
98 
Let's personalize your content